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Abstract
Objective:  The  prevalence  of  allergic  conjunctivitis  (AC)  has  not  been  established.  Estimates
suggest that  ocular  allergies  affect  15%  to  20%  of  the  worldwide  population,  yet  most  epidemi-
ological  studies  encompass  nasal  and  ocular  allergy  symptoms  and  have  not  been  speciﬁc  to  AC.
The  aim  of  this  study  was  to  verify  the  prevalence  of  ocular  allergy  symptoms,  co-morbidities,
and their  impact  on  adolescents.
Methods: Adolescents  were  selected  from  a  sample  of  schools,  and  completed  in  classrooms  a
previously  validated  questionnaire  on  symptoms  of  AC.  AC  diagnosis  was  considered  when  more
than  three  episodes  of  ocular  itching  were  reported  in  the  past  12  months.  Related  symptoms
such  as  tearing,  photophobia,  foreign  body  sensation,  impact  on  daily  activities,  and  diagnosis
of  AC  were  analyzed.
Results: Questionnaires  were  obtained  from  3,120  adolescents  (mean  age  13.3  ±  1.1  years).
Ocular itching  in  the  past  12  months  occurred  in  1,592  (51%).  The  most  frequently  associ-
ated  symptom  was  tearing  (74%),  followed  by  photophobia  (50.1%)  and  foreign  body  sensation
(37.1%).  The  prevalence  of  AC  was  20.7%,  affecting  more  females  than  males  (56.1%  versus
45.9%;  p  =  0.01).  The  risks  of  an  adolescent  with  ocular  allergy  to  present  asthma,  rhinitis,  and
atopic  eczema  were  (OR  =  5.7;  95%  CI:  4.5  to  7.1),  (OR  =  3.6;  95%  CI:  3.0  to  4.3),  and  (OR  =  2.6;
95%  CI:  2.0  to  3.5),  respectively.  Severe  interference  in  daily  activities  was  reported  by  30.5%.
Conclusions:  Symptoms  of  ocular  allergy  are  common,  frequently  associated  to  other  allergic
diseases, and  impact  the  daily  activities  of  adolescents.
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Epidemiologia  da  alergia  ocular  e  comorbidades  em  adolescentes
Resumo
Objetivo:  A  prevalência  de  conjuntivite  alérgica  (CA)  não  foi  estabelecida.  Estimativas  sugerem
que alergias  oculares  afetam  de  15  a  20%  da  populac¸ão  mundial,  ainda  que  a  maioria  dos  estudos
epidemiológicos  abranjam  sintomas  de  alergia  nasal  e  ocular  e  não  sejam  especíﬁcos  a  respeito
da  CA.  O  objetivo  deste  estudo  foi  veriﬁcar  a  prevalência  de  sintomas,  comorbidades  e  o  impacto
da  alergia  ocular  em  adolescentes.
Métodos: Os  adolescentes  foram  selecionados  de  uma  amostra  de  escolas  e  preencheram,  em
sala  de  aula,  um  questionário  previamente  validado  sobre  os  sintomas  da  CA.  O  seu  diagnóstico
foi  considerado  quando  mais  de  três  episódios  de  prurido  ocular  foram  relatados  nos  últimos  12
meses.  Sintomas  relacionados,  como  lacrimejamento,  fotofobia,  sensac¸ão  de  corpo  estranho,
impacto  sobre  as  atividades  diárias  e  diagnóstico  de  conjuntivite  alérgica,  foram  analisados.
Resultados:  Foram  obtidos  questionários  de  3.120  adolescentes  (média  de  13,3  ±  1,1  ano).  Nos
últimos  12  meses,  1.592  (51%)  adolescentes  tiveram  prurido  ocular.  O  sintoma  relacionado  mais
frequente  foi  lacrimejamento  (74%),  seguido  de  fotofobia  (50,1%)  e  sensac¸ão  de  corpo  estranho
(37,1%).  A  prevalência  de  conjuntivite  alérgica  foi  de  20,7%,  afetando  mais  pessoas  do  sexo
feminino  do  que  do  masculino  (56,1%  em  comparac¸ão  a  45,9%;  p  =  0,01).  O  risco  de  um  adoles-
cente  com  alergia  ocular  apresentar  asma,  rinite  e  eczema  atópico  foi  (RC  =  5,7;  CI  de  95%:  4,5
a  7,1);  (RC  =  3,6;  CI  de  95%:  3,0  a  4,3)  e  (RC  =  2,6;  CI  de  95%:  2,0  a  3,5),  respectivamente.  Uma
interferência  grave  nas  atividades  diárias  foi  relatada  por  30,5%.
Conclusões:  Sintomas  de  alergia  ocular  são  comuns,  frequentemente  relacionados  a  outras
doenc¸as alérgicas,  e  causam  impacto  sobre  as  atividades  diárias  de  adolescentes.
© 2013  Sociedade  Brasileira  de  Pediatria.  Publicado  por  Elsevier  Editora  Ltda.  
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Este é um artigo Open Access sob a licença de CC BY-NC-NDIntroduction
Ocular  allergy  (OA)  is  a  general  term  to  describe  different
phenotypes, of  which  seasonal  and  perennial  allergic  con-
junctivitis (AC)  represent  the  majority  of  diagnoses.  Severe
conditions, such  as  atopic  keratoconjunctivitis  and  vernal
keratoconjunctivitis, affect  a  smaller  number  of  patients.1
There  are  few  data  on  OA  epidemiology.  Allergies  are  con-
siderably underreported,  and  incidence  has  a  wide  variation
depending on  geographic  location,  which  interferes  with
estimates on  prevalence  of  OA.  A  survey  conducted  by  the
American College  of  Allergy,  Asthma,  and  Immunology  found
that 35%  of  families  interviewed  experienced  allergies,  of
which more  than  50%  reported  associated  eye  symptoms.2
The  importance  of  OA  results  mainly  from  its  frequency,
which ranges  from  5%  to  22%  of  the  population.3
Some  studies  have  proposed  the  concept  of  ‘one  disease’
for asthma  and  allergic  rhinitis.  Recent  data  have  also  sug-
gested that  AC  may  be  part  of  this  entity,  based  on  the  fact
that most  patients  suffering  from  allergic  rhinitis  also  com-
plain of  ocular  symptoms.4 In  contrast,  it  has  been  shown
that allergic  ocular  symptoms  were  the  only  manifestation
of allergy  in  approximately  25%  of  allergic  adults.5 OA  is
increasingly recognized  as  a  distinct  symptom  that  imposes
its own  burden  on  patient’s  quality  of  life.6
In  adolescents,  most  of  the  epidemiological  data,  includ-
ing data  from  different  phases  of  the  International  Study  on
Asthma and  Allergies  in  Childhood  (ISAAC),  associate  ocular
symptoms with  nasal  symptoms,  so  it  is  difﬁcult  to  separate
the prevalence  of  AC  from  that  of  allergic  rhinitis.  This  study
aimed to  determine  the  OA  prevalence  and  co-morbidities
in schoolchildren.
‘
i
cethods
his  was  a  cross-sectional  study  conducted  between  April
nd May  of  2009  in  Curitiba,  State  of  Paraná,  Brazil.  The
urvey reached  students  of  seventh  and  eighth  grades  to
nclude most  of  13  and  14  year  olds  up  to  a  minimum  of
,000 participants.  Information  regarding  the  schools  was
rovided by  the  Paraná  Department  of  Education.  In  2009,
here were  253  schools  in  Curitiba,  which  were  alphabeti-
ally ordered  and  randomized  by  computer.  This  sample  size
as power  of  90%  to  detect  differences  of  2%  in  prevalence  at
% signiﬁcance  level.  The  survey  administration  techniques
ollowed the  ISAAC  phase  I standardized  method.7
Subjects  fulﬁlled  a  validated  questionnaire  from  the
SAAC core  questionnaire  for  13  and  14  year  olds,  which  com-
rised eight  items  on  OA  symptoms  (Fig.  1)8 and  11  relevant
tems on  asthma,  rhinitis,  and  atopic  eczema  symptoms.7
OA  was  deﬁned  as  more  than  three  episodes  of  ocular
tching reported  in  the  last  12  months.  Subjects  with  symp-
oms occurring  only  between  September  and  December,
hich is  the  grass  pollen  season  in  the  area,  were  classi-
ed as  having  seasonal  symptoms,  whereas  patients  with
ymptoms occurring  both  during  and  apart  from  the  grass
ollen season  were  classiﬁed  as  having  perennial  symptoms.
o investigate  the  burden  of  OA,  children  were  asked  how
uch their  eye  problem  had  interfered  with  daily  activities
n the  last  12  months.  Those  who  responded  ‘not  at  all’  or
a little’  were  classiﬁed  as  ‘mild,’  whereas  those  responding
a moderate  amount’  or  ‘a  lot’  were  classiﬁed  as  ‘severe.’
Asthma  was  considered  as  positive  responses  to  wheez-
ng in  the  last  12  months.  Frequent  asthma  symptoms  were
onsidered when  more  than  three  attacks  of  wheezing  were
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Item Question
1) Have you ever had a problem with itchy eyes?
( )Yes ( ) No
2) In the past 12 months, have you had problem with itchy eyes?
( )Yes ( ) No
3) At anytime, was the problem with the eyes accompanied by any of the following: 
Tearing; ( )Yes ( ) No
Difficulty  in looking toward lights; ( )Yes ( ) No
Feeling ofsand in the eyes? ( )Yes ( ) No
4) In the past 12 months, how many times did you experience any of the following: 
Tearing; ( )Yes ( ) No
Difficulty  in looking toward the lights; ( )Yes ( ) No
Feeling ofsand in the eyes? ( )Yes ( ) No
5) In the past 12 months, how many times did you have problems with itchy eyes?
( ) None
( ) 1 to 3
( ) 4 to 12
( ) More than 12
6) In the past 12 months how did the problem with the eyes interfered with your daily activities?
( ) Not at all
( ) A little
( ) Average
( ) A lot
7) In the past 12 months, in which months did you have the eye problems?
( ) January ( ) February ( ) March ( ) April ( ) May ( ) June ( ) July ( ) August ( ) September ( ) 
October
( ) November ( ) December
8) Have you ever had allergic conjunctivitis?
( ) Yes ( ) No
9) Have you ever had wheezing or whistling in the chest at any time in the past? 
( ) Yes ( ) No
10) Have you had wheezing or whistling in the chest in the last 12 months?
( ) Yes ( ) No
11) How many attacks of wheezing have you had in the last 12 months?
( ) None
( ) 1 to 3
( ) 4 to 12 
( ) More than 12 
12) In the last 12 months, how often, on average, has your sleep been disturbed due to wheezing?
( ) Never woken with wheezing 
( ) Less than one night per week 
( ) One or more nights per week
13) Have you ever had asthma?
( ) Yes ( ) No
14) Have you ever had a problem with sneezing, or a runny or blocked nose when you DID NOT 
have a cold or the flu?
( ) Yes ( ) No
15) In the past 12 months, have you had a problem with sneezing, or a runny or blocked nose when 
you DID NOT have a cold or the flu?
( ) Yes ( ) No
16) In the past 12 months, has this nose problem been accompanied by itchy !watery eyes?
( ) Yes ( ) No
17) Have you ever had an intermittent itchy rash for at least six months?
( ) Yes ( ) No
18) Have you had an itchy rash at any time in the last 12 months?
( ) Yes ( ) No
19) Has an itchy rash at any time affected any of the following places: the folds of the elbows, behind 
the knees, in front of the ankles, under the buttocks, or around the neck, ears or eyes?
( ) Yes ( ) No
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wFigure  1  Questionnaire  on  ocular  allergy,  asthma
eported,  and  severe  asthma  symptoms  when  the  adoles-
ent had  sleep  disturbances  due  to  wheezing.  Rhinitis  was
eﬁned when  symptoms  (sneezing,  runny  or  blocked  nose)
ere present  in  the  absence  of  cold  or  the  ﬂu.  Atopic  eczema
as considered  when  a  recurrent  itchy  rash  affecting  skin
olds, for  at  least  six  months,  had  occurred.  To  reduce  errors
t
o
onoconjunctivitis,  and  atopic  dermatitis  symptoms.
f  recall,  only  symptoms  occurring  in  the  last  12  months
ere considered.
The statistical  package  StatCalc-7® was  used  to  analyze
he data.  The  response  rate  was  calculated  as  the  number
f completed  written  questionnaires  divided  by  the  number
f participants.  The  proportion  of  adolescents  with  allergic
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Table  1  Prevalence  of  ocular  allergy  symptoms  in  adolescents  (n  =  3,120).
n  (%)  95%  CI
Tearing
One  to  three  episodes 892  (28.6) 27.0--30.2
>three  episodes  479  (15.3)  14.1--16.7
Difﬁculty in  looking  at  light
One to  three  episodes  488  (15.6)  14.4--17.0
>three 324  (10.4)  9.4--11.5
Foreign body  sensation
One to  three  episodes  505  (16.2)  14.9--17.5
>three episodes  240  (7.7)  6.8--8.9
Ocular itching
One to  three  episodes  945  (30.3)  28.7--31.9
>three episodes  647  (20.7)  19.3--22.2
Ocular itching  and  tearing  1378  (44.2)  42,4--45,9
Ocular itching  and  difﬁculty  in  looking  at  light  725  (23.2)  21.8--24.7
Ocular itching  and  foreign  body  sensation  793  (25.4)  23.9--27.0
w
9
y
s
e
p
(
oCI, conﬁdence interval.
symptoms  was  calculated  with  a  95%  conﬁdence  interval
(CI). Pearson’s  chi-squared  test  was  used  to  compare  cate-
gorical variables.  The  signiﬁcance  level  was  0.05.  The  odds
ratio (OR)  and  95%  CI  was  used  to  verify  the  strength  of  asso-
ciation between  OA  and  the  other  atopic  conditions  (asthma,
rhinitis, and  atopic  eczema).  The  study  was  approved  by
the institutional  review  board,  and  informed  consent  was
obtained from  all  participants.Results
There  were  3,468  subjects  approached;  68  did  not  consent
and 280  did  not  complete  the  questionnaire  correctly.  There
r
f
a
n
Table  2  Prevalence  of  allergic  diseases  and  characteristics  amon
n  (%)  
Prevalence  of  allergic  diseases  (n  =  3,120)
Ocular  allergy  647  (20.7)
Asthma 636  (20.4)
Rhinitis 1,246  (39.9)
Atopic eczema  221  (7.1)  
Characteristics among  those  who  had  over  three  episodes  of  ocu
Daily  life  interferencea
Mild  450  (69.5)
Severe 197  (30.5)
Seasonalityb
Seasonal  137  (21.2)
Perennial 510  (78.8)
Ever had  allergic  conjunctivitisc 305  (47.1)
CI, conﬁdence interval.
a Mild symptoms in the past 12 months: if they responded ‘not at all’
responded ‘a moderate amount’ or ‘a lot’.
b Seasonal allergic conjunctivitis: symptoms occurring only betwee
symptoms occurring both inside/outside the September--December per
c Afﬁrmative response to the question: ‘Have you ever had allergic cere  3,120  adolescents  included;  the  response  rate  was
1.8% (51.2%  females).  The  age  varied  between  12  and  18
ears old  (mean  13.3  ±  1.1  years  old).  The  prevalence  of
ymptoms of  OA  was  20.7%  (Table  1).  Among  those  consid-
red as  having  OA,  30.5%  had  severe  symptoms  (79%  were
erennial), and  47%  reported  a  previous  diagnosis  of  AC
Table 2).
OA-related co-morbidities  are  shown  in  Table  3.  At  least
ne co-morbidity  (asthma,  rhinitis,  or  atopic  eczema)  was
eported by  75.3%  of  children  with  OA.  Rhinitis  was  the  most
requent co-morbidity  (64.6%).  Asthma  occurred  in  31.4%
nd atopic  eczema  in  13.1%.  The  number  of  children  with
one, one,  two  or  three  allergy-related  co-morbidities  is
g  those  who  had  over  three  episodes  of  ocular  itching.
95%  CI
 (19.3--22.2)
 (19.0--21.8)
 (38.2--41.7)
(6.2--8.0)
lar  itching  (n  =  647)
 (65.9--80.0)
 (27.0--34.1)
 (18.2--25.0)
 (75.5--81.8)
 (43.3--81.0)
 or ‘a little’ for daily life interference; severe symptoms: if they
n September and December; perennial allergic conjunctivitis:
iod.
onjunctivitis?’.
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Table  3  Co-morbidities  of  ocular  allergy  in  children  (n  =  647).
Ocular  allergy
n  (%)  OR  (95%  CI)  p
Rhinitis  418  (64.6)  3.6  (3.0--4.3)  <0.01
Asthma 203  (31.4)  5.7  (4.5--7.1)  <0.01
Frequent symptomsa 79  (12.2)  3.6  (2.7--5.0)  <0.01
Severe symptomsb 109  (16.9)  2.6  (2.1--3.3)  <0.01
Atopic eczema  85  (13.1)  2.6  (2.0--3.5)  <0.01
CI, conﬁdence interval; OR, odds ratio.
a More than 3 episodes of wheezing in the last 12 months.
b Sleep disturbed because of wheeze in the last 12 months.
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telated co-morbidities  (asthma,  rhinitis  and  atopic  eczema)  of
cular allergy  (percent  given  above  each  bar).
hown  in  Fig.  2.  Co-morbidities  of  perennial  versus  sea-
onal OA  compared  through  the  chi-squared  test  showed  that
hinitis was  more  common  in  those  with  perennial  symp-
oms (66.7%  versus  56.9%;  p  =  0.034),  whereas  asthma  and
topic eczema  did  not  differ  between  the  two  groups  (33.1%
ersus 24.8%;  p  =  0.062)  and  (12.3%  versus  16%;  p  =  0.25),
espectively. Daily  life  interference  was  greater  in  those
ith perennial  symptoms  (22.7%  versus  13.1%;  p  <  0.01).
The probability  of  an  adolescent  with  OA  to  show  asthma,
hinitis, and  atopic  eczema  was  (OR  =  5.7;  95%  CI:  4.5  to
.1); (OR  =  3.6;  95%  CI:  3.0  to  4.3)  and  (OR  =  2.6;  95%  CI:
.0 to  3.5),  respectively.  The  association  between  asthma
nd OA  was  greater  among  those  with  both  OA  and  rhinitis
han those  with  OA  only  (36.8%  versus  20.5%;  p <  0.01).
iscussion
ritten  questionnaires  have  been  widely  used  in  epidemi-
logical studies  of  allergic  diseases.  The  prevalence  of
sthma, rhinoconjunctivitis,  and  atopic  eczema  have  been
eriﬁed and  compared  throughout  the  globe.  However,  OA
ymptoms are  less  studied,  and  most  of  epidemiological
tudies have  evaluated  eyes  and  nasal  symptoms  combined,
o it  is  difﬁcult  to  analyze  the  prevalence  of  OA  and  its
elationship with  other  allergic  diseases.There  are  few  validated  questionnaires  to  study  OA.  In  a
ase-control study  involving  102  subjects,  more  than  three
pisodes of  ocular  itching  in  the  last  12  months  was  predic-
ive of  OA  with  sensitivity  of  85.4%  and  speciﬁcity  of  85.1%.8
i
n
Olthough  not  pathognomonic,  recurrent  ocular  itching  is  the
ost frequent  symptom  of  OA9 and  it  is  the  ﬁrst  symptom
bserved in  allergen  conjunctival  challenge.10 Patients  with
lepharitis, eczema,  keratoconjunctivitis  sicca,  and  other
ypes of  conjunctivitis  may  occasionally  present  with  ocular
tching.11
The  questionnaire  was  designed  speciﬁcally  to  assess
revalence of  OA  symptoms,  and  a  high  response  rate  was
btained.8 Ocular  itching  was  identiﬁed  in  51%  of  partic-
pants. The  prevalence  of  OA  was  20.7%,  considering  the
riterion of  more  than  three  episodes  of  ocular  itching  in
he last  12  months.  In  the  US,  ocular  itching  and  tear-
ng were  identiﬁed  in  40%  of  20,010  participants  in  the
ational Health  and  Nutrition  Examination  Survey.5 In  Swe-
en, response  to  a  written  questionnaire  followed  by  a
ubsequent interview  of  396  schoolchildren  aged  12  to  13
ears estimated  the  cumulative  prevalence  of  AC  of  19.1%,12
hile  in  Turkey  the  overall  prevalence  of  AC  in  children  6-
4 years  was  7.1%.13 In  Karachi,  Pakistan,  818  children  aged
etween 5  and  19  years  underwent  vision  assessment  and
lit lamp  examination  by  an  ophthalmologist.  Diagnosis  of  AC
as  conﬁrmed  in  19.2%,  considering  the  presence  of  papil-
ae in  the  upper  tarsal  conjunctiva,  redness  of  the  eyes,  and
istory of  itching  and  burning.14
The  prevalence  of  OA  has  a  wide  variation  between
eographic areas  not  only  due  to  genetic  differences  and
nvironmental factors,  but  also  due  to  the  lack  of  standard-
zation in  the  assessment  of  ocular  symptoms  by  validated
ethods. The  ISAAC  phase  III  comprised  304,679  adoles-
ents aged  13-14  years  from  56  countries,  and  demonstrated
hat the  prevalence  of  nasal  symptoms  associated  with  itchy
atery eyes  ranged  from  4.5%  to  45.1%  among  adolescents.15
n  the  ISAAC,  there  were  no  questions  regarding  isolated  AC
ymptoms,  and  the  opportunity  to  verify  its  prevalence  was
issed. If  validated  questions  for  ocular  symptoms  had  been
ncluded, the  identiﬁcation  of  the  prevalence  of  AC  and  its
elationship with  other  allergic  diseases  could  have  been
acilitated.16
In  this  study,  lacrimation  was  associated  in  73.9%  of  ado-
escents with  OA.  After  exposure  of  the  ocular  surface  to
llergens, there  is  a  late  phase  reaction  with  cell  inﬁltrate
hat could  lead  to  obstruction  of  the  nasolacrimal  duct.  Tear-
ng caused  by  neuronal  reﬂex  has  also  been  observed  after
asal provocation  tests17.
‘Difﬁculty  in  looking  at  light’  was  reported  by  45.7%  of
A participants.  It  is  important  to  distinguish  this  symptom
c
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from  photophobia,  which  when  detected,  suggests  alterna-
tive diagnosis  as  iritis  and  uveitis.18 Foreign  body  sensation
occurs when  there  is  a  break  in  the  corneal  epithelium,
exposing sensitive  corneal  nerves  to  the  opening  and  closing
of the  eyelids.19 This  symptom  was  reported  by  20%  of  those
with OA.
Conjunctival hyperemia  is  a  common  symptom  of  OA,  but
it is  nonspeciﬁc.  In  recent  years,  an  increase  in  the  preva-
lence of  red  eye  has  occurred  due  to  an  increase  in  the  use
of contact  lenses  and  exposure  to  irritants  such  as  tobacco
smoke and  pollutants.20
Seasonal  AC  (SAC)  and  perennial  AC  (PAC)  are  the  most
prevalent types  of  OA.  SAC  is  reported  to  be  more  com-
mon than  PAC  in  temperate  climate  countries.11 However,
in tropical  climates,  perennial  symptoms  appear  to  be  more
common. A  study  from  Thailand  with  445  patients  with  AC
has showed  that  81.8%  had  PAC.  Most  of  them  were  sensi-
tized to  Dermatophagoides  pteronyssinus  (Dp)  (70.2%)  and
house dust  (67.5%).21 In  this  study,  78.8%  of  subjects  with
OA had  perennial  symptoms.  In  addition,  when  symptoms
were perennial  there  was  a  stronger  association  with  rhini-
tis and  greater  impact  in  daily  life  activities  compared  with
seasonal symptoms.  In  1999,  a  study  to  evaluate  atopic
sensitization in  this  population  demonstrated  that  skin  sen-
sitization to  Dp  and  Lolium  multiﬂorum  (Lm)  in  3,271  13  to
14 year-old  schoolchildren  was  31.3%  and  4.7%,  respectively.
Whereas in  3,041  adults,  positive  skin  prick  test  was  38.9%  to
Dp and  15.4%  to  Lm.22 These  ﬁndings  suggest  that  perennial
allergens are  important  triggering  agents  in  this  population.
Approximately  one  ﬁfth  of  the  students  with  OA  reported
that ocular  symptoms  caused  moderate  or  severe  inter-
ference in  daily  activities,  though  more  speciﬁc  questions
related to  quality  of  life  have  not  been  included  in  this  evalu-
ation. In  rhinitis,  studies  have  shown  that  this  question  was
well correlated  with  other  indicators  of  morbidity,  includ-
ing reported  symptom  severity,  interference  with  speciﬁc
activities of  daily  living,  and  medical  service  use.7 In  the
Allergies in  America  Survey,  23%  of  AR  patients  found  red,
itchy eyes  to  be  extremely  bothersome  and  20%  said  the
same for  watery  eyes.23 Ten  percent  of  patients  surveyed
believed that  red,  itchy  eyes  were  their  most  bothersome
symptom.
Despite the  high  prevalence  of  OA  and  important  morbid-
ity it  imposes,  the  disease  is  often  under-diagnosed.  Half  of
the subjects  considered  as  having  OA  answered  ‘yes’  to  the
question ‘Have  you  had  AC?’,  suggesting  that  OA  is  under-
recognized. It  is  known  that  OA  symptoms  may  not  become
severe enough  to  lead  patients  to  visit  their  doctors.  A  study
performed in  Portugal  with  220  patients  with  AC  demon-
strated that,  although  signiﬁcant  impairment  of  quality  of
life had  been  observed  during  acute  episodes  of  OA,  only
19.4% had  an  appointment  with  an  ophthalmologist  as  a  ﬁrst
action and  37.2%  had  previous  allergic  evaluation.24
OA  is  also  under-recognized  by  physicians.  In  a  review  of
medical records  of  1,549  asthmatic  patients  from  a  tertiary
referral hospital,  681  (44%)  had  at  least  one  ocular  symptom
suggestive of  OA.  However  AC  was  diagnosed  only  in  16%  by
the attending  physician.25It  is  common  to  face  associations  between  allergic
conditions. However,  few  studies  have  evaluated  OA  comor-
bidities. In  the  present  study,  OA  was  often  associated
with at  least  one  allergic  condition.  Rhinitis  was  the  most359
ommon,  followed  by  asthma  and  atopic  eczema.  Rhinocon-
unctivitis has  been  identiﬁed  as  a  risk  factor  for  asthma.
he prevalence  rate  of  RCA  between  asthmatics  may  be  as
igh as  90%.26 For  individuals  studied  in  Curitiba,  the  odds
atios of  an  adolescent  with  OA  to  have  asthma,  rhinitis,  and
topic eczema  were  six,  four,  and  three  times,  respectively.
he association  between  asthma  and  OA  was  greater  among
hose with  both  OA  and  rhinitis.  It  is  not  known  why  the  com-
ination of  symptoms  varies  among  allergic  patients.  In  a
irth cohort  study  with  404  unselected  6-year-old  children,
t was  suggested  that  the  link  between  allergic  disorders
ends to  be  stronger  in  those  with  IgE-mediated  reaction.27
The  present  study  has  provided  information  of  isolated
A epidemiology.  From  the  public  health  perspective,  it  is
mportant to  diagnose,  treat,  and  evaluate  comorbidities  of
atients with  OA,  since  this  disease  is  highly  prevalent  and
requently associated  with  other  allergic  diseases.  Assessing
isk factors  and  the  allergic  status  of  these  patients  should
e the  focus  of  future  epidemiological  studies  on  AC.
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